Health ❯Diabetes ❯Treatment Options ❯Dipeptidyl Peptidase-4 Inhibitors
NIH-funded research shows a modest reduction in obesity-related cancer risk and all-cause mortality among diabetic adults using GLP-1 receptor agonists, with notable benefits for women.
